First Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary Intervention
暂无分享,去创建一个
R. Becker | S. Zelenkofske | Mauricio G. Cohen | J. Alexander | R. Harrington | M. Chan | L. Grinfeld | C. Rusconi | A. Greenbaum | E. Fry | J. Rossi | Laura H. Aberle | Shelley K. Myles | R. Tonkens | D. Purdy | Drew A. Purdy